BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 17962203)

  • 1. Results of plasma N-terminal pro B-type natriuretic peptide and cardiac troponin monitoring in GIST patients do not support the existence of imatinib-induced cardiotoxicity.
    Perik PJ; Rikhof B; de Jong FA; Verweij J; Gietema JA; van der Graaf WT
    Ann Oncol; 2008 Feb; 19(2):359-61. PubMed ID: 17962203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic assessment of elderly patients with symptoms of heart failure by combining high-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide measurements.
    Alehagen U; Dahlström U; Rehfeld JF; Goetze JP
    Clin Chem; 2010 Nov; 56(11):1718-24. PubMed ID: 20844063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-Terminal Pro B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin T Levels Are Related to the Extent of Hibernating Myocardium in Patients With Ischemic Heart Failure.
    Zelt JGE; Liu PP; Erthal F; deKemp RA; Wells G; O'Meara E; Garrard L; Beanlands RSB; Mielniczuk LM
    Can J Cardiol; 2017 Nov; 33(11):1478-1488. PubMed ID: 28966019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure.
    de Antonio M; Lupon J; Galan A; Vila J; Urrutia A; Bayes-Genis A
    Am Heart J; 2012 May; 163(5):821-8. PubMed ID: 22607860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined measurement of N-terminal pro-B-type natriuretic peptide and highly sensitive cardiac troponin T for diagnosis and monitoring of heart injury in chronic Chagas' disease.
    Munoz Saravia SG; Haberland A; Bartel S; Araujo R; Valda G; Reynaga DD; Ramirez ID; Borges AC; Wallukat G; Ziebig R; Schimke I
    Clin Biochem; 2013 Oct; 46(15):1615-8. PubMed ID: 23810852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rare incidence of congestive heart failure in gastrointestinal stromal tumor and other sarcoma patients receiving imatinib mesylate.
    Trent JC; Patel SS; Zhang J; Araujo DM; Plana JC; Lenihan DJ; Fan D; Patel SR; Benjamin RS; Khakoo AY
    Cancer; 2010 Jan; 116(1):184-92. PubMed ID: 19885836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-biomarker risk stratification of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and cardiac troponin T and I in end-stage renal disease for all-cause death.
    Apple FS; Murakami MM; Pearce LA; Herzog CA
    Clin Chem; 2004 Dec; 50(12):2279-85. PubMed ID: 15364888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac troponin T and NT-proBNP as diagnostic and prognostic biomarkers of primary cardiac involvement and disease severity in systemic sclerosis: A prospective study.
    Bosello S; De Luca G; Berardi G; Canestrari G; de Waure C; Gabrielli FA; Di Mario C; Forni F; Gremese E; Ferraccioli G
    Eur J Intern Med; 2019 Feb; 60():46-53. PubMed ID: 30366614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between high-sensitivity cardiac troponin T and N-terminal pro-brain natriuretic peptide in a community based population.
    Xu R; Ye P; Luo L; Sheng L; Wu H; Xiao W; Zheng J; Wang F; Xiao T
    Chin Med J (Engl); 2014; 127(4):638-44. PubMed ID: 24534215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reference interval evaluation of high-sensitivity troponin T and N-terminal B-type natriuretic peptide in Vietnam and the US: The North South East West Trial.
    Gaggin HK; Dang PV; Do LD; deFilippi CR; Christenson RH; Lewandrowski EL; Lewandrowski KB; Truong BQ; Pham VQ; Vu VH; Vu TV; Nguyen TB; Belcher AM; Femia A; Kelley C; Januzzi JL
    Clin Chem; 2014 May; 60(5):758-64. PubMed ID: 24568795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The duration of the use of imatinib mesylate is only weakly related to elevated BNP levels in chronic myeloid leukaemia patients.
    Marcolino MS; Boersma E; Clementino NC; Nunes Mdo C; Barbosa MM; Silva MH; Geleijnse ML; Ribeiro AL
    Hematol Oncol; 2011 Sep; 29(3):124-30. PubMed ID: 20860069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving Prediction of Postoperative Myocardial Infarction With High-Sensitivity Cardiac Troponin T and NT-proBNP.
    Kopec M; Duma A; Helwani MA; Brown J; Brown F; Gage BF; Gibson DW; Miller JP; Novak E; Jaffe AS; Apple FS; Scott MG; Nagele P
    Anesth Analg; 2017 Feb; 124(2):398-405. PubMed ID: 28002165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imatinib for the treatment of patients with unresectable and/or metastatic gastrointestinal stromal tumours: systematic review and economic evaluation.
    Wilson J; Connock M; Song F; Yao G; Fry-Smith A; Raftery J; Peake D
    Health Technol Assess; 2005 Jul; 9(25):1-142. PubMed ID: 15985189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imatinib mesylate: in the treatment of gastrointestinal stromal tumours.
    Croom KF; Perry CM
    Drugs; 2003; 63(5):513-22; discussion 523-4. PubMed ID: 12600228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-terminal pro-B-type natriuretic peptide and cardiac troponin T in non-immune hydrops.
    Lee SM; Jun JK; Kim SA; Kang MJ; Song SH; Lee J; Park CW; Park JS
    J Obstet Gynaecol Res; 2016 Apr; 42(4):380-4. PubMed ID: 26787625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial 2D strain echocardiography and cardiac biomarkers in children during and shortly after anthracycline therapy for acute lymphoblastic leukaemia (ALL): a prospective study.
    Mavinkurve-Groothuis AM; Marcus KA; Pourier M; Loonen J; Feuth T; Hoogerbrugge PM; de Korte CL; Kapusta L
    Eur Heart J Cardiovasc Imaging; 2013 Jun; 14(6):562-9. PubMed ID: 23109647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congestive heart failure during imatinib mesylate treatment.
    Turrisi G; Montagnani F; Grotti S; Marinozzi C; Bolognese L; Fiorentini G
    Int J Cardiol; 2010 Nov; 145(1):148-50. PubMed ID: 19656583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Coronary Atherosclerosis and Myocardial Ischemia on Plasma Levels of High-Sensitivity Troponin T and NT-proBNP in Patients With Stable Angina.
    Caselli C; Prontera C; Liga R; De Graaf MA; Gaemperli O; Lorenzoni V; Ragusa R; Marinelli M; Del Ry S; Rovai D; Giannessi D; Aguade-Bruix S; Clemente A; Bax JJ; Lombardi M; Sicari R; Zamorano J; Scholte AJ; Kaufmann PA; Knuuti J; Underwood SR; Clerico A; Neglia D
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):757-64. PubMed ID: 26868212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profiles of cardiovascular biomarkers according to severity stages of Chagas cardiomyopathy.
    Echeverría LE; Rojas LZ; Calvo LS; Roa ZM; Rueda-Ochoa OL; Morillo CA; Muka T; Franco OH
    Int J Cardiol; 2017 Jan; 227():577-582. PubMed ID: 27839809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrointestinal stromal tumor (GIST) -- single center experience of prolonged treatment with imatinib.
    Schindler CG; Armbrust T; Gunawan B; Langer C; Füzesi L; Ramadori G
    Z Gastroenterol; 2005 Mar; 43(3):267-73. PubMed ID: 15765299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.